SARAH GILFILLAN: Open Payments
NPI 1043971435 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $183 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $104 |
| ABBVIE INC. | 3 | $69 |
| Ardelyx, Inc. | 2 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| GENZYME CORPORATION | 1 | $28 |
| Lilly USA, LLC | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
Products named: TREMFYA, LINZESS, IBSRELA, DUPIXENT, XIFAXAN, OMVOH, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
